Evidence map›Paper›PMID 40207098›Full record

ArticleClinical kidney journal2025

Predicting acute kidney injury in trauma using an extreme gradient boosting model.

Yongjin Yi, Minwoo Tae, Sujong Shin, Sang-Il Choi

Abstract read
In one paragraph

Article in Clinical kidney journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yongjin YiDepartment of Internal Medicine, College of Medicine, Dankook University, Dongnam-gu, Chungcheongnam-do, Cheonan-si, Republic of Korea.ORCID https://orcid.org/0000-0001-8553-7189
Minwoo TaeDepartment of Artificial Intelligence-based Convergence, Dankook University, Suji-gu, Gyeonggi-do, Yongin-si, Republic of Korea.
Sujong ShinDepartment of Artificial Intelligence-based Convergence, Dankook University, Suji-gu, Gyeonggi-do, Yongin-si, Republic of Korea.
Sang-Il ChoiDepartment of Computer Engineering, Dankook University, Gyeonggi-do, Yongin-si, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Acute kidney injury (AKI) is a significant complication in patients with trauma. The early identification of AKI in these patients poses challenges. This study aimed to predict AKI in trauma patients 24 or 48 hours in advance using an extreme gradient boosting (XGBoost) model. Methods: We analyzed 17 859 trauma patients admitted to a regional trauma center between January 2015 and July 2023. Demographic, clinical, and laboratory parameters were collected. The model was developed using data until July 2021 and validated using data from August 2021. We developed models to predict AKI stages 1-3 and AKI stages 2 and 3 occurring 48 and 24 hours later and measured predictive performance in the validation group. The models' performance was evaluated using the area under the receiver operating characteristic curve (AUROC), and feature importance was assessed through SHapley Additive exPlanations values. Results: The study population exhibited an incidence of AKI of 6.6% in the development group and 5.4% in the validation group. The models demonstrated predictive performance with AUROCs of 0.864 and 0.886 for 48-hour predictions of AKI stages 1-3 and stages 2 and 3, and 0.904 and 0.903 for 24-hour predictions of AKI stages 1-3 and stages 2 and 3, respectively. Key features influencing model predictions included baseline and in-hospital serum creatinine values, injury severity score, age, lactate dehydrogenase, D-dimer, platelets, albumin, and C-reactive protein levels. Conclusions: The XGBoost models effectively predicted AKI in trauma patients up to 48 hours in advance using clinical data.

Indexed as

acute kidney injurygradient boostingmachine learningROC curvetrauma

Identifiers

PMID40207098
PMCPMC11980976

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.